Page last updated: 2024-10-20

pyrazinamide and Leishmaniasis, American

pyrazinamide has been researched along with Leishmaniasis, American in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"Pyrazinamide (PZA) is a constituent of short-course tuberculosis chemotherapy."1.35The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells. ( Cynamon, MH; Green, P; Hinchman, M; Huang, L; Mendez, S; Traslavina, R; Welch, JT, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mendez, S1
Traslavina, R1
Hinchman, M1
Huang, L1
Green, P1
Cynamon, MH1
Welch, JT1

Other Studies

1 other study available for pyrazinamide and Leishmaniasis, American

ArticleYear
The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; B7-1 Antigen; B7-2 Antigen; Cell Line; Cell Su

2009